Form 4: Lemaitre Vascular Director Bridget A. Ross Reports Acquisition of Dividend Equivalent Rights

Director Bridget A. Ross reported the acquisition of dividend equivalent rights related to restricted stock units and performance share units.

Summary

• On March 27, 2025, Bridget A. Ross, a director of Lemaitre Vascular Inc. (LMAT), reported the acquisition of dividend equivalent rights.
• These rights are associated with restricted stock unit (RSU) and performance share unit (PSU) awards previously granted to Ross.
• The dividend equivalent rights vest proportionately with the underlying RSU and PSU awards.
• Each dividend equivalent right represents the economic equivalent of one share of Lemaitre Vascular's common stock.
• The acquired dividend equivalent rights are reported as being held directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and alignment of director interests with shareholders through equity-based awards.

Industry Context

This filing is a routine disclosure related to director compensation and equity awards, common in the healthcare and medical device industry.

Stakeholder Impact

• The acquisition of dividend equivalent rights aligns the director's interests with those of shareholders, as the value of these rights is tied to the performance of the company's stock.

Key Dates

Keywords

Form 4, Dividend Equivalent Rights, Lemaitre Vascular, Director, Ross, LMAT, RSU, PSU